Your browser doesn't support javascript.
loading
Anisotropic silk nanofiber layers as regulators of angiogenesis for optimized bone regeneration.
Fan, Zhihai; Liu, Hongxiang; Shi, Shilei; Ding, Zhaozhao; Zhang, Zhen; Lu, Qiang; Kaplan, David L.
Afiliação
  • Fan Z; Department of Orthopedics, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, 215000, PR China.
  • Liu H; Department of Orthopedics, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, 215000, PR China.
  • Shi S; Department of Orthopedics, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, 215000, PR China.
  • Ding Z; National Engineering Laboratory for Modern Silk & Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, Suzhou, 215123, PR China.
  • Zhang Z; Department of Dermatology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200011, PR China.
  • Lu Q; National Engineering Laboratory for Modern Silk & Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, Suzhou, 215123, PR China.
  • Kaplan DL; Department of Biomedical Engineering, Tufts University, Medford, MA, 02155, United States.
Mater Today Bio ; 15: 100283, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35634170
ABSTRACT
Osteogenesis-angiogenesis coupling processes play a crucial role in bone regeneration. Here, electric field induced aligned nanofiber layers with tunable thickness were coated on the surface of pore walls inside the deferoxamine (DFO)-laden silk fibroin (SF) and hydroxyapatite (HA) composite scaffolds to regulate the release of DFO to control vascularization dynamically. Longer electric field treatments resulted in gradually thickening layers to reduce the release rate of DFO where the released amount of DFO decreased gradually from 84% to 63% after 28 days. Besides the osteogenic capacity of HA, the changeable release of DFO brought different angiogenic behaviors in bone regeneration process, which provided a desirable niche with osteogenic and angiogenic cues. Anisotropic cues were introduced to facilitate cell migration inside the scaffolds. Changeable cytokine secretion from endothelial cells cultured in the different scaffolds revealed the regulation of cell responses related to vascularization in vitro. Peak expression of angiogenic factors appeared at days 7, 21 and 35 for endothelial cells cultured in the scaffolds with different silk nanofier layers, suggesting the dynamical regulation of angiogenesis. Although all of the scaffolds had the same silk and HA composition, in vitro cell studies indicated different osteogenic capacities for the scaffolds, suggesting that the regulation of DFO release also influenced osteogenesis outcomes in vitro. In vivo, the best bone regeneration occurred in defects treated with the composite scaffolds that exhibited the best osteogenic capacity in vitro. Using a rat bone defect model, healing was achieved within 12 weeks, superior to those treated with previous SF-HA composite matrices. Controlling angiogenic properties of bone biomaterials dynamically is an effective strategy to improve bone regeneration capacity.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article